StockData
ResMed Inc logo

ResMed Inc (RMD) stock

RMDNYSESurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RSMDF
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 21/3012% below fair value
$235.63−1.25 (-0.53%)

Close on Nov 20, 2026Market cap $33.14BP/E 21.5Yield 1.02%

ResMed free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

ResMed's free cash flow for the twelve months ending Sep 30, 2026 was $1.61B, down 9.0% year over year. For fiscal 2026 it was $1.65B, down 0.7% from the year before. Over ten years it grew 12.9% a year on average. The highest annual figure on record is $1.66B in fiscal 2025.

Annual free cash flow

PeriodPeriod endValueChange
FY2026Jun 30, 2026$1.65B-0.7%
FY2025Jun 30, 2025$1.66B+27.6%
FY2024Jun 30, 2024$1.30B+126.9%
FY2023Jun 30, 2023$573.63M+165.2%
FY2022Jun 30, 2022$216.31M-65.9%
FY2021Jun 30, 2021$634.01M-10.3%
FY2020Jun 30, 2020$706.93M+81.1%
FY2019Jun 30, 2019$390.34M-11.8%
FY2018Jun 30, 2018$442.45M+25.8%
FY2017Jun 30, 2017$351.83M-28.1%
FY2016Jun 30, 2016$489.40M+52.6%
FY2015Jun 30, 2015$320.68M+0.7%
FY2014Jun 30, 2014$318.55M-6.1%
FY2013Jun 30, 2013$339.24M+1.0%
FY2012Jun 30, 2012$336.02M+55.1%
FY2011Jun 30, 2011$216.58M+64.9%
FY2010Jun 30, 2010$131.36M+1.7%
FY2009Jun 30, 2009$129.19M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Sep 30, 2026$373.68M-9.8%
Q4 FY2026CQ2 2026Jun 30, 2026$403.50M-20.6%
Q3 FY2026CQ1 2026Mar 31, 2026$520.48M-6.7%
Q2 FY2026CQ4 2025Dec 31, 2025$311.21M+8.1%
Q1 FY2026CQ3 2025Sep 30, 2025$414.36M+34.7%
Q4 FY2025CQ2 2025Jun 30, 2025$508.18M+22.4%
Q3 FY2025CQ1 2025Mar 31, 2025$557.87M+46.5%
Q2 FY2025CQ4 2024Dec 31, 2024$287.98M+15.4%
Q1 FY2025CQ3 2024Sep 30, 2024$307.70M+20.1%
Q4 FY2024CQ2 2024Jun 30, 2024$415.23M+104.6%
Q3 FY2024CQ1 2024Mar 31, 2024$380.84M+50.1%
Q2 FY2024CQ4 2023Dec 31, 2023$249.48M+146.3%
Q1 FY2024CQ3 2023Sep 30, 2023$256.25M+1542.0%
Q4 FY2023CQ2 2023Jun 30, 2023$202.99M+299.2%
Q3 FY2023CQ1 2023Mar 31, 2023$253.75M+267.8%
Q2 FY2023CQ4 2022Dec 31, 2022$101.29M-46.5%
Q1 FY2023CQ3 2022Sep 30, 2022$15.61M–
Q4 FY2022CQ2 2022Jun 30, 2022$50.84M-74.4%
Q3 FY2022CQ1 2022Mar 31, 2022$68.99M-59.4%
Q2 FY2022CQ4 2021Dec 31, 2021$189.47M+40.4%
Q1 FY2022CQ3 2021Sep 30, 2021-$93.00M-171.3%
Q4 FY2021CQ2 2021Jun 30, 2021$198.62M-36.4%
Q3 FY2021CQ1 2021Mar 31, 2021$169.92M-19.1%
Q2 FY2021CQ4 2020Dec 31, 2020$134.97M+201.1%
Q1 FY2021CQ3 2020Sep 30, 2020$130.50M-6.6%
Q4 FY2020CQ2 2020Jun 30, 2020$312.30M+161.1%
Q3 FY2020CQ1 2020Mar 31, 2020$210.11M+68.7%
Q2 FY2020CQ4 2019Dec 31, 2019$44.83M-59.6%
Q1 FY2020CQ3 2019Sep 30, 2019$139.69M+297.7%
Q4 FY2019CQ2 2019Jun 30, 2019$119.62M+7.0%
Q3 FY2019CQ1 2019Mar 31, 2019$124.56M-8.5%
Q2 FY2019CQ4 2018Dec 31, 2018$111.04M-4.8%
Q1 FY2019CQ3 2018Sep 30, 2018$35.13M-54.9%
Q4 FY2018CQ2 2018Jun 30, 2018$111.80M-8.3%
Q3 FY2018CQ1 2018Mar 31, 2018$136.12M+156.9%
Q2 FY2018CQ4 2017Dec 31, 2017$116.58M+10.8%
Q1 FY2018CQ3 2017Sep 30, 2017$77.95M–
Q4 FY2017CQ2 2017Jun 30, 2017$121.95M–
Q3 FY2017CQ1 2017Mar 31, 2017$52.99M–
Q2 FY2017CQ4 2016Dec 31, 2016$105.21M–

More ResMed figures

See a number that looks wrong?